Pharmaceutical labs commit significant capital to acquiring cutting-edge equipment. However, these sophisticated instruments often experience low utilization, resulting in a substantial financial burden. Underutilized equipment represents a loss offunds and can negatively affect a lab's throughput. Quantifying the scope of this A: We’re not about